January 10, 2013in Blogs, Commercialization, Competition, European Union, Human Rights, Innovation, Patent Practice, Patentability, Patents, Regulatory Policy, Trade Secrets, US2by Editor3616 Live and Let Die: Gene Patenting Plot Thickens as the Patent/Trade Secret Line is Blurred The long battle in the American courts over Myriad Genetics’ patents of BRCA1 and BRCA2, the primary diagnostic genes for hereditary breast and ovarian cancer has been well-documented in the…
